Skip to main content

Table 1 Baseline pretreatment laboratory profiles of 86 participants in the initial cross-sectional cohort

From: Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning

Parameters Mean ± SD
Age (years) 37.6 ± 7.3
Waist (cm) 80.2 ± 12.0
BMI (kg/m2) 24.2 ± 4.9
Blood lead level (μg/dL) 81.4 ± 9.8
Hemoglobin (g/dL) 13.4 ± 1.6
White blood cell count (103/μL) 8.0 ± 1.8
Platelets (1012/L) 285.6 ± 58.4
Creatinine (mg/dL) 0.9 ± 0.3
Total bilirubin (mg/dL) 0.8 ± 0.4
Direct bilirubin (mg/dL) 0.3 ± 0.1
Alkaline phosphatase (U/L) 68.8 ± 19.5
SGOT (U/L) 30.7 ± 28.9
SGPT (U/L) 33.3 ± 33.2
Liver stiffness (kPa) 5.4 ± 0.9
CAP (dB/m) 225.1 ± 49.3
  1. Abbreviations: SGOT serum glutamate oxaloacetate transaminase, SGPT serum glutamate pyruvate aminotransferase, CAP controlled attenuation parameters